About Insight Strategy Advisors
Insight Strategy Advisors is a Healthcare company based in New York (United States) founded in 2002 by Harry Schiavi, and was acquired by Precision Medicine Group in January 2018. Strategy consulting is provided for pharma and biopharma sectors. Its chief executive, as recorded, is Harry Schiavi. Its focus areas include Biopharma Outsourcing, Consulting, Business and Market Access & HEOR. Its competitors include Target RWE, Secura Bio and STATinMED Research; 1 of its 3 listed competitors has raised funding.
Company details
Insight Strategy Advisors (ISA) is a management and strategy consulting firm for pharma biopharma industries . The company provides consulting services such as market access, pricing, commercialization, data analytics reimbursement strategy for pharmaceutical products at pre-FDA approval, post-approval loss of exclusivity stage. The company claims that it has worked with 18 of the top 30 global pharmaceutical biopharmaceutical companies. Precision Value Health acquired Insight Strategy Advisors in Jan 2018.
- Headquarters New York, United States
- Founders Harry Schiavi
- Stage Acquired
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website insightstrategyadvisors.com
- Social LinkedIn X
- Acquired by Precision Medicine Group (Jan 2018)
- Investors
- Acquired byPrecision Medicine Group
(Jan 2018)
Investors in Insight Strategy Advisors
Insight Strategy Advisors has secured backing from 1 investor. Prominent investors backing the company include Precision Medicine Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of clinical research, development, and commercialization services for life sciences | 2012 | precisionmedicinegrp.com | Bethesda, United States |
Investor details for Insight Strategy Advisors
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Insight Strategy Advisors
1 people are tracked at Insight Strategy Advisors (1 in leadership).
| Name | Role | Group |
|---|---|---|
Harry Schiavi | Co-Founder, Owner, President & CEO | Leadership |
Complete people profiles for Insight Strategy Advisors
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Insight Strategy Advisors
2 dated milestones of Insight Strategy Advisors across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Insight Strategy Advisors is founded.
- Exit Acquired by Precision Medicine Group.
Competitors of Insight Strategy Advisors
Insight Strategy Advisors has 3 listed competitors in our database, 1 of them funded. They include Target RWE, Secura Bio and STATinMED Research.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| targetrwe.com | 2017 | Durham, United States | 116 | Marketing services to the pharmaceutical industry are provided. | ||
| securabio.com | 2018 | Henderson, United States | $55M | Consulting services for market access and health outcomes are provided. | ||
| statinmed.com | 2007 | Ann Arbor, United States | Healthcare data analytics services provider |
Detailed competitors of Insight Strategy Advisors
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Insight Strategy Advisors (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Insight Strategy Advisors
Insight Strategy Advisors was founded in 2002.
Insight Strategy Advisors is headquartered in New York, United States. It is registered at New York, New York, United States.
Harry Schiavi is the CEO of Insight Strategy Advisors, as recorded in our data. They have also founded this company.
Insight Strategy Advisors (ISA) is a management and strategy consulting firm for pharma biopharma industries . The company provides consulting services such as market access, pricing, commercialization, data analytics reimbursement strategy for pharmaceutical products at pre-FDA approval, post-approval loss of exclusivity stage. The company claims that it has worked with 18 of the top 30 global pharmaceutical biopharmaceutical companies. Precision Value Health acquired Insight Strategy Advisors in Jan 2018.
Insight Strategy Advisors's top competitors include Target RWE, STATinMED Research and Secura Bio.
Insight Strategy Advisors has 1 investor. Key investors include Precision Medicine Group.
Yes. Insight Strategy Advisors was acquired by Precision Medicine Group in January 2018.
